2E5-16163-09857
4 vaccinations
2 coded responses
36 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 223 / VA
- Registered
- 2021-04-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Dose 1 — Pfizer-BioNTech
-
2021-04-02
Dose 2 — Pfizer-BioNTech
-
2021-04-03
Registered in v-safe
-
2021-04-03
Survey response — days 1–6 daily, dose 2MedDRA: Palpitations, Pyrexia — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Low grade fever, racing heart off and onMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-09
- 2021-07-02
- 2021-10-01
-
2021-10-04
Dose 3 — Pfizer-BioNTech
- 2021-10-04
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2022-01-05
- 2022-04-04
-
2022-04-27
Dose 4 — Pfizer-BioNTech
-
2022-04-27
Health check-in — day 0, dose 4Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2022-04-28
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2022-04-29
- 2022-04-30
- 2022-05-01
- 2022-05-02
-
2022-05-03
Survey response — days 1–6 daily, dose 4MedDRA: SARS-CoV-2 test positive — Feeling: Good · Fatigue or tirednessFree text: But I did test positive for covid 5/2MedDRA releases: 2024-11 · check-in free text available
- 2022-05-04
- 2022-05-11
- 2022-05-18
- 2022-05-25
- 2022-06-01
- 2022-06-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Pfizer-BioNTech | |
| 2 | 2021-04-02 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
| 4 | 2022-04-27 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-03 | priority 2/3 |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Low grade fever, racing heart off and on
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): But I did test positive for covid 5/2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Palpitations | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
| SRO | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release